These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 18591436)

  • 1. Transcriptomic biomarkers for individual risk assessment in new-onset heart failure.
    Heidecker B; Kasper EK; Wittstein IS; Champion HC; Breton E; Russell SD; Kittleson MM; Baughman KL; Hare JM
    Circulation; 2008 Jul; 118(3):238-46. PubMed ID: 18591436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes and predictors of recovery in acute-onset cardiomyopathy: A single-center experience of patients undergoing endomyocardial biopsy for new heart failure.
    Gilotra NA; Bennett MK; Shpigel A; Ahmed HM; Rao S; Dunn JM; Harrington C; Freitag TB; Halushka MK; Russell SD
    Am Heart J; 2016 Sep; 179():116-26. PubMed ID: 27595686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Selvester QRS score as a predictor of cardiac events in nonischemic dilated cardiomyopathy.
    Hiraiwa H; Okumura T; Sawamura A; Sugiura Y; Kondo T; Watanabe N; Aoki S; Ichii T; Kitagawa K; Kano N; Fukaya K; Furusawa K; Morimoto R; Takeshita K; Bando YK; Murohara T
    J Cardiol; 2018 Mar; 71(3):284-290. PubMed ID: 29066100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of cardiac stability after weaning from left ventricular assist devices in patients with idiopathic dilated cardiomyopathy.
    Dandel M; Weng Y; Siniawski H; Potapov E; Drews T; Lehmkuhl HB; Knosalla C; Hetzer R
    Circulation; 2008 Sep; 118(14 Suppl):S94-105. PubMed ID: 18824777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endomyocardial miR-133a levels correlate with myocardial inflammation, improved left ventricular function, and clinical outcome in patients with inflammatory cardiomyopathy.
    Besler C; Urban D; Watzka S; Lang D; Rommel KP; Kandolf R; Klingel K; Thiele H; Linke A; Schuler G; Adams V; Lurz P
    Eur J Heart Fail; 2016 Dec; 18(12):1442-1451. PubMed ID: 27292200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocyte diameter and fractional area of collagen are not associated with survival time of outpatients with idiopathic dilated cardiomyopathy: a study based on right ventricular endomyocardial biopsies.
    Benvenuti LA; Freitas HF; Mansur AJ; Higuchi ML
    Int J Cardiol; 2007 Mar; 116(2):279-80. PubMed ID: 16839625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The proposed new classification of coronary microcirculation as the predictor of the heart failure progression in idiopathic dilated cardiomyopathy.
    Gil KE; Pawlak A; Frontczak-Baniewicz M; Gil RJ; Nasierowska-Guttmejer A
    Cardiovasc Pathol; 2015; 24(6):351-8. PubMed ID: 26382083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of morphometric endomyocardial biopsy analysis in patients with idiopathic dilated cardiomyopathy.
    Grimm W; Rudolph S; Christ M; Pankuweit S; Maisch B
    Am Heart J; 2003 Aug; 146(2):372-6. PubMed ID: 12891210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of coronary angiography, left heart catheterization, and endomyocardial biopsy for the diagnosis of idiopathic dilated cardiomyopathy.
    Figulla HR; Kellermann AB; Stille-Siegener M; Heim A; Kreuzer H
    Am Heart J; 1992 Nov; 124(5):1251-7. PubMed ID: 1442493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ischemic cardiomyopathy: endomyocardial biopsy and ventriculographic evaluation of patients with congestive heart failure, dilated cardiomyopathy and coronary artery disease.
    Hare JM; Walford GD; Hruban RH; Hutchins GM; Deckers JW; Baughman KL
    J Am Coll Cardiol; 1992 Nov; 20(6):1318-25. PubMed ID: 1430681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gene expression profile of patients with new-onset heart failure reveals important gender-specific differences.
    Heidecker B; Lamirault G; Kasper EK; Wittstein IS; Champion HC; Breton E; Russell SD; Hall J; Kittleson MM; Baughman KL; Hare JM
    Eur Heart J; 2010 May; 31(10):1188-96. PubMed ID: 20031959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical impact of myocardial mTORC1 activation in nonischemic dilated cardiomyopathy.
    Yano T; Shimoshige S; Miki T; Tanno M; Mochizuki A; Fujito T; Yuda S; Muranaka A; Ogasawara M; Hashimoto A; Tsuchihashi K; Miura T
    J Mol Cell Cardiol; 2016 Feb; 91():6-9. PubMed ID: 26739211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline Characteristics Predict the Presence of Amyloid on Endomyocardial Biopsy.
    Ton VK; Bhonsale A; Gilotra NA; Halushka MK; Steenbergen C; Almansa J; Brown E; Tedford RJ; Wittstein I; Sharma K; Russell SD; Judge DP
    J Card Fail; 2017 Apr; 23(4):340-344. PubMed ID: 28011000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct comparison of the diagnostic capability of cardiac magnetic resonance and endomyocardial biopsy in patients with heart failure.
    Yoshida A; Ishibashi-Ueda H; Yamada N; Kanzaki H; Hasegawa T; Takahama H; Amaki M; Asakura M; Kitakaze M
    Eur J Heart Fail; 2013 Feb; 15(2):166-75. PubMed ID: 23329703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclophilin A predicts clinical outcome in patients with congestive heart failure undergoing endomyocardial biopsy.
    Zuern CS; Müller KA; Seizer P; Geisler T; Banya W; Klingel K; Kandolf R; Bauer A; Gawaz M; May AE
    Eur J Heart Fail; 2013 Feb; 15(2):176-84. PubMed ID: 23243067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results in patients with idiopathic dilated cardiomyopathy after weaning from left ventricular assist devices.
    Dandel M; Weng Y; Siniawski H; Potapov E; Lehmkuhl HB; Hetzer R
    Circulation; 2005 Aug; 112(9 Suppl):I37-45. PubMed ID: 16159848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and prognostic utility of right-sided catheterization and endomyocardial biopsy in idiopathic dilated cardiomyopathy.
    Popma JJ; Cigarroa RG; Buja LM; Hillis LD
    Am J Cardiol; 1989 Apr; 63(13):955-8. PubMed ID: 2929470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T1-Mapping and Outcome in Nonischemic Cardiomyopathy: All-Cause Mortality and Heart Failure.
    Puntmann VO; Carr-White G; Jabbour A; Yu CY; Gebker R; Kelle S; Hinojar R; Doltra A; Varma N; Child N; Rogers T; Suna G; Arroyo Ucar E; Goodman B; Khan S; Dabir D; Herrmann E; Zeiher AM; Nagel E;
    JACC Cardiovasc Imaging; 2016 Jan; 9(1):40-50. PubMed ID: 26762873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic implications of a combined diagnostic workup including endomyocardial biopsy in an all-comer population of patients with heart failure: a retrospective analysis.
    Sotiriou E; Heiner S; Jansen T; Brandt M; Schmidt KH; Kreitner KF; Emrich T; Schultheiss HP; Schulz E; Münzel T; Wenzel P
    ESC Heart Fail; 2018 Aug; 5(4):630-641. PubMed ID: 29745463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial gene expression in heart failure patients treated with cardiac resynchronization therapy responders versus nonresponders.
    Vanderheyden M; Mullens W; Delrue L; Goethals M; de Bruyne B; Wijns W; Geelen P; Verstreken S; Wellens F; Bartunek J
    J Am Coll Cardiol; 2008 Jan; 51(2):129-36. PubMed ID: 18191736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.